Announced prior to MD&M West, the cables connect the endoscope and camera control unit to transport high-resolution, high-frame-rate, 4K MIPI D-PHY-based video over up to 5 meters
SANTA CLARA, Calif. & MUNICH, April 06, 2022--(BUSINESS WIRE)--OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, and Silicon Line, the world leader in ultra-low-power optical link technology, today announced the availability of long (2 to 5 meters), thin and flexible optical cables for endoscopes and catheters. Silicon Line’s SL85018 serializer/de-serializer (SerDes) IC provides data transmission for OMNIVISION’s high-resolution, full HD and 4K MIPI D-PHY-based image sensors, without having any significant heat or excessive power consumption.
The solution uses only one extremely thin optical fiber in place of 10 copper wires for ultra-thin, light and flexible cables between the endoscope camera and camera control unit (CCU). Silicon Line’s ultra-low power SerDes consumes only 24mW at the camera end of the cable, minimizing heat generation. The SerDes IC is just 1.4mm x 1.5mm (bare die) or 5mm x 5mm (UBGA package) in size and can easily be incorporated into a HD/4K endoscope designs. Additionally, these optical cables provide the necessary EMC/EMI shielding from the patient as per IEC 60601 requirements.
"There is a significant need for higher resolution and image quality for gastrointestinal (GI) and airway management endoscopes, which usually use 1080p to 4K2K image sensors running at 60 frames per second. This requires high-speed data transfer of up to 16 Gbps over the length of the endoscope that can be up to 5 meters," said Tehzeeb Gunja, director of medical marketing at OMNIVISION. "We are pleased to partner with Silicon Line to enable high bandwidth video to be transported over several meters with thin and flexible optical fiber cables that have low system power consumption and are cost-comparative versus copper cables."
According to Ian Jackson, director of sales and marketing, Silicon Line, "Our proven and reliable optical link solution decreases time to market for our customer base for reusable endoscopes. The technology also supports dual camera operation over the same single fiber. Our expertise in the high-volume consumer market means the bill of materials cost is low so the high-volume reusable endoscope market is a good match for this technology."
The cables will be available in mid-2022. Please visit OMNIVISION for a demonstration during MD&M West, April 12-14, booth 1275. For more information, contact your OMNIVISION sales representative: www.ovt.com/contact-sales.
Silicon Line GmbH is the global leader in ultra-low-power optical link technology enabling thin, light weight and long ultra-high-speed cables for consumer electronics, commercial, industrial and medical applications. The company develops and manufactures integrated circuits and modules that allow a simple, low-cost, high-volume assembly of active optical cables. Founded in 2005, Silicon Line is based in Munich, Germany with offices in Korea, Japan, Taiwan, China and the United States. For more information, visit: https://www.silicon-line.com/.
OMNIVISION is a global fabless semiconductor organization that develops advanced digital imaging, analog, and touch & display solutions for multiple applications and industries, including mobile phones; security and surveillance; automotive; computing; medical; and emerging applications. Its award-winning innovative technologies enable a smoother human/machine interface in many of today’s commercial devices. Find out more at www.ovt.com.
OMNIVISION™, OVMed®, CameraCubeChip® and the OMNIVISION logo are trademarks or registered trademarks of OMNIVISION. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005358/en/
OMNIVISION Media Contact: Sandy Fewkes Kiterocket +1 408.529.9685 sfewkes@kiterocket.com
OMNIVISION Company Contact: Mengxi Liu OMNIVISION +1 408.653.3484 mengxi.liu@ovt.com
Silicon Line Contact: Ian Jackson Silicon Line GmbH +49 89.5463700.130 Ian.Jackson@silicon-line.com
One day after Boeing (NYSE: BA) stock bounced higher on news of a big 737 plane sale to the parent company of British Airways and Iberia (the International Consolidated Airlines Group), shares of the airplane-building juggernaut are falling 7.2% as of 1:10 p.m. ET. The reason: Boeing may be encountering turbulence at higher altitudes. Earlier on Thursday, the big news around Boeing was the company's announcement that International Airlines Group has agreed to buy 25 Boeing 737-8-200 aircraft and 25 737 MAX 10 jetliners -- and taken out an option to buy as many as 100 more planes besides.
Shares of the artificial intelligence lender Upstart Holdings (NASDAQ: UPST) traded more than 16% lower as of 11:14 a.m. ET today after it received yet another downgrade from Wall Street. Wedbush analyst David Chiaverini maintained his underperform rating on Upstart but lowered his price target from $20 to $15 per share. The lower price target comes just a week after Chiaverini lowered his price target on Upstart from $35 to $20.
Yahoo Finance Live anchors discuss allegations that Elon Musk sexually harassed a flight attendant in 2016.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).
Yahoo Finance Live anchors discuss second-quarter earnings for Deere.
Shares of Nvidia (NASDAQ: NVDA) continued to tumble on Friday, falling as much as 8%. Wells Fargo analyst Aaron Rakers lowered his price target on Nvidia to $250, down from $370, while maintaining his overweight (buy) rating on the stock, according to The Fly.
Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.
Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.
In this article, we discuss 10 buy-the-dip stocks to buy according to billionaire Ken Fisher. If you want to skip our detailed analysis of Fisher’s stock selection and the current sell-off in tech, go directly to 5 Best Buy-the-Dip Tech Stocks According to Billionaire Ken Fisher. The tech-heavy Nasdaq Composite is down 27% in 2022 […]
When legends speak, people listen – and few investors match the legendary status of Ray Dalio. The founder of Bridgewater Associates has built his firm from a 2-room apartment operation into the world’s largest hedge fund, with more than $150 billion in assets under management, and a net gain exceeding $46 billion. Dalio believes that the next two to four years will see our global economic and political systems change in ways that are unpredictable now. And the key to survival, for investors, ma
Investors weren't overjoyed about a fresh debt offering announced by Carnival, and a bearish new note from an analyst didn't help, either. After market hours on Wednesday, Carnival announced that it is floating a private offering of $1 billion worth of senior unsecured notes. Carnival says it plans to use the net proceeds of the issue to make scheduled principal payments on debt during fiscal 2023 and for general corporate purposes.
In early trading Friday, stock markets attempted to make a comeback and at least end a losing week on a winning note. As of 12:25 p.m. ET, shares of Rivian Automotive (NASDAQ: RIVN) are off 4.9%, Nikola (NASDAQ: NKLA) stock is down 5.8%, and Lucid Group (NASDAQ: LCID) -- the beneficiary of positive news as recently as yesterday -- is giving back most of its gains, and leading the sector 6.8% lower today.
Athersys Inc's (NASDAQ: ATHX) partner, Healios K.K. has reported topline results for its Japan ischemic stroke study, TREASURE. The study included patients with moderate to moderate-severe ischemic stroke administered a single dose of MultiStem cells (invimestrocel) or placebo by intravenous infusion within 18-36 hours of the event. The primary endpoint, Excellent Outcome at 90 days, did not reach statistical significance in this population. Overall, consistent improvement in essentially all mea
Shares of the e-commerce platform company Shopify (NYSE: SHOP) were plunging today just one day after its share price soared by double digits. Today's drop was caused by ongoing fears about high inflation and upcoming Federal Reserve interest rate hikes. As a result, the tech-heavy Nasdaq Composite had slid 2.5% and Shopify's stock had tumbled 10.8% as of 2:44 p.m. ET.
Nio (NYSE: NIO) shares began trading on the main board of the Singapore stock exchange today prior to the opening of the U.S. markets. After initially popping 20% early, the new shares ended up closing in Singapore about 2.4% higher, according to Barron's.
In this article, we discuss 6 stocks that Warren Buffett is selling in 2022. If you want to see more stocks that the billionaire sold, click Warren Buffett is Selling These 3 Stocks in 2022. Warren Buffett, the chief of Berkshire Hathaway, is perhaps the most renowned financier in the investment world, with decades of […]
Your retirement savings are $1 million. You want $100,000 of yearly retirement income, including Social Security. Is that doable without tons of risk?
The veteran tech giant just completed a multi-year turnaround. Here's the investment opportunity with the new IBM.
Like many tech and fintech stocks this year, the Berkshire Hathaway-backed Brazilian digital bank Nu Holdings (NYSE: NU) has seen its stock price struggle and is down more than 61% this year. Nu is a major disruptor in the Latin American banking space, first offering a credit card with no annual fees and then building out a suite of banking products from there. Nu has amassed close to 60 million customers but in the past has gotten questions regarding its high valuation and path to sustainable profitability.
In this article, we discuss Michael Burry’s short position in Apple Inc. (NASDAQ:AAPL) and the 5 stocks he is selling in 2022. If you want to skip our analysis of Burry’s history, investment philosophy, and hedge fund performance, go directly to Michael Burry Is Selling These 3 Stocks in 2022. Michael Burry was born on […]